澳大利亚和新西兰床旁诊断超声市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00033417
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 137
Buy Now

Australia and New Zealand Point-of-Care Diagnostic Ultrasound Market Growth 2030

Buy Now

澳大利亚和新西兰的床旁诊断超声市场规模预计将从2022年的6601万美元增长到2030年的8353万美元;预计 2022 年至 2030 年复合年增长率为 5.24%。
分析师的观点
护理点超声 (POCUS) 在澳大利亚和新西兰的急诊科中得到越来越多的采用,目前已在被认为是急诊医生的基本能力。技术进步有可能减少澳大利亚农村和偏远地区医疗保健获取和可用性问题的负面影响。技术很可能会进一步进步,更多的用户将能够使用紧凑型、手持式和便携式超声机器。
与过去相比,澳大利亚医疗机构提供了更多种类的 POCUS 设备。澳大利亚昆士兰州凯恩斯医院实施了最先进的迈瑞 TEX20 最新高端 POC 超声,使急诊临床医生能够解决资源稀缺、患者群体多样化以及缺乏后续护理等障碍。越来越多的择期手术和紧急情况产生了对利用 POC 超声对各种病症进行更安全、准确和实时诊断的需求。然而,熟练技术人员的短缺影响了 2022-2030 年澳大利亚和新西兰床旁诊断超声市场的预测。
市场洞察
由于慢性病发病率不断上升以及需要紧急护理的患者数量各种健康疾病,如急性腹痛、泌尿系统问题和剧烈胸痛,对床旁超声 (POCUS) 设备的需求激增。 POCUS 有助于患者护理、提高医疗程序效率、减少并发症并节省关键时间。 POCUS 诊断肺部疾病的准确性相当于甚至高于诊断特定肺部疾病的实验室标记物。因此,这些疾病的发病率和需要紧急护理的患者的不断增加预计将成为澳大利亚和新西兰床旁诊断超声市场预测的主要驱动力之一。
POCUS 已广泛应用于许多学科作为一种快速诊断工具,尤其是在急诊医学领域。 POCUS 允许急诊科的医师助理 (PA) 或执业护士 (NP) 立即获取、解释和临床整合超声成像。在急诊科,可以借助这些设备进行各种临床应用,例如 FAST 检查、聚焦回波、肺部超声检查、液体引流和其他一些程序。 POCUS 已用于帮助诊断多种医疗状况,从急性阑尾炎、气道受损、腹主动脉瘤到创伤评估。因此,急诊部门拥有 POCUS 非常重要,这样他们才能高效、有效、有能力处理各种紧急情况。 POCUS 相对较快的使用使其成为正式放射学检查可能延迟诊断的潜在选择。因此,急救护理中越来越多地采用床旁诊断超声,从而推动澳大利亚和新西兰床旁诊断超声市场在预测期内的增长。
未来趋势
超声设备开始融合了机器人技术、云计算、5G 网络、人工智能 (AI) 和远程技术。随着时间的推移,超声系统已发展成为具有强大成像和通信能力的先进终端平台。此外,通常更需要且更适合满足许多临床专业和科室不断增长的需求和规格,专门的超声设备。远程 POCUS 是一种通过使用现代计算机、网络连接和多媒体技术以数字方式重建 POCUS 图像来远程获取、存储、传输、分析和处理照片的技术。通过高精度同步,可以通过文本、音频、视频等多通道连接实现远程实时诊断和介入治疗。 POCUS领域的此类技术预计将扩大澳大利亚和新西兰的即时诊断超声市场规模。
实时、远距离、高分辨率、高带宽、低延迟的要求近年来,通过发展5G技术,满足了机器人手术和远程超声会诊的需求,这使得高质量传输POCUS成像并将其作为宝贵的医疗资源共享成为可能。这为远程 POCUS 技术的广泛应用打开了大门。因此,床旁超声自动化的日益普及预计将推动澳大利亚和新西兰床旁诊断超声市场未来的增长。

报告细分和范围
“澳大利亚和新西兰即时诊断超声市场”根据技术、便携性、应用和最终用户进行细分。根据技术,市场分为 2D、3D/4D 等。基于便携性,市场分为手推车和紧凑/手持式。从应用来看,澳大利亚和新西兰的现场诊断超声市场分为普通成像、心脏病学、外科手术等。根据最终用户,市场分为急诊、重症监护/重症监护、手术室、试管婴儿诊所、理疗中心、运动医学、全科医生、呼吸中心、麻醉和普通病房。
基于技术的见解
根据技术,澳大利亚和新西兰的护理点超声诊断市场分为 2D、3D/4D 等。到 2022 年,2D 细分市场将占据澳大利亚和新西兰床旁诊断超声市场的最大份额。预计 3D/4D 细分市场从 2022 年到 2030 年的复合年增长率最高。在超声领域,B 模式是一种创造机会的环境。超声屏幕上的二维 (2D) 灰度图像是最常用的模式。一般称为2D模式。 2D 超声系统在市场上很容易买到,而且价格实惠。 2D 超声波使用在一个平面上传输和接收的高频非电离声波。通常,二维超声用于诊断孕妇胎儿的健康状况。它会生成黑白图像,显示婴儿的骨骼结构,并使内部器官清晰可见。护理点超声 (POCUS) 生成的 2D 图像使医疗保健专业人员能够实时可视化器官、血管和其他结构,从而帮助诊断和指导手术。与其他技术相比,2D 超声更易于使用、省时且具有成本效益。此外,先进的图像质量和快速的结果导致诊断中心使用该技术。
基于便携性的见解
基于便携性,澳大利亚和新西兰的护理点超声诊断市场分为手推车和紧凑型/手持式。 2022 年,手推车细分市场在澳大利亚和新西兰床旁诊断超声市场中占据较大份额,预计 2022 年至 2030 年复合年增长率最高。推车式超声是一种便携式超声设备,通常在医疗环境中用于诊断成像目的。它使医疗保健专业人员能够在床边方便地诊断卧床不起的患者,而无需中断治疗。基于推车的诊断超声波可以方便地从医院和诊断中心的一个位置移动到另一个位置。这些设备适用于监测胎儿和患者。
该系统的成本效益以及不需要更多空间的事实使其成为小型诊所和医生的普遍采用选择。该系统的多功能性、用户友好的功能、更多地采用成像技术来诊断疾病,以及在急症护理和紧急护理环境中更多地使用基于推车的超声波,支持了澳大利亚和新西兰这一细分市场的增长。护理诊断超声市场。
基于应用的见解
在应用方面,澳大利亚和新西兰的护理诊断超声市场分为普通成像、心脏病学、外科等。 2022 年,心脏病学细分市场占据澳大利亚和新西兰床旁诊断超声市场最大份额。预计普通成像细分市场在 2022 年至 2030 年期间复合年增长率最高。 POC 超声是指医疗保健提供者在患者床边或临床环境中使用便携式超声设备。在一般成像中,POC 超声提供实时可视化并帮助诊断各种医疗状况。它为各种医疗环境提供了可访问性和便携性。其紧凑和便携的特性使医疗保健提供者能够在患者床边进行成像研究,从而更容易实时评估不同的解剖结构和器官系统。而且,POC超声具有成本效益,增强了患者护理,提高了诊断速度,并提高了一般影像中医学评估的效率和准确性。它是一种快速且易于使用的初步评估工具,可指导进一步的诊断和治疗决策。
基于最终用户的见解
根据最终用户,澳大利亚和新西兰的护理点超声诊断市场进行了细分急诊科、重症监护/重症监护、手术室、试管婴儿诊所、物理治疗中心、运动医学、全科医生、呼吸中心、麻醉和普通病房。 2022 年,急诊科细分市场占据澳大利亚和新西兰床旁诊断超声市场最大份额,预计在预测期内复合年增长率最高。
澳大利亚和新西兰床旁诊断超声市场,最终用户 – 2022 年和 2030 年
国家分析
传统上,超声波是超声医师、专业放射科医生和心脏病专家的领域。随着护理点超声的引入,这种情况发生了变化,现在超声在各个专业中用于诊断和手术指导。澳大利亚乡村医生认为产科扫描是 POCUS 实践的重要组成部分。由于长期缺乏训练有素的超声医师,澳大利亚农村和偏远地区的孕妇获得及时超声服务的机会少于大都市和偏远地区的孕妇。
根据澳大利亚健康与福利研究所 2021 年癌症数据,癌症是一种该国疾病和死亡的主要原因。 2021 年,澳大利亚新诊断出约 151,000 例癌症病例,平均每天 413 例。同年,该国约有 49,000 人死于癌症,平均每天有 135 人死亡。此外,预计到 2023 年,结直肠癌将成为美国第四大确诊癌症,当年报告病例约为 15,400 例。 POCUS 已被证明是诊断胃肠道癌症的准确技术。因此,上述因素支持了澳大利亚和新西兰现场诊断超声市场在预测期内的增长。
该报告介绍了在澳大利亚和新西兰现场运营的领先企业-护理诊断超声市场。其中包括 GE 医疗集团;蝴蝶网络公司;富士胶片; Esoate SpA;豪洛捷公司;回声公司;皇家飞利浦公司;深圳迈瑞生物医疗电子有限公司;这些公司专注于新产品的发布和地域扩张,以满足全球不断增长的消费者需求,并增加其专业产品组合的产品范围。他们在全球范围内拥有广泛的业务,这使他们能够为大量客户提供服务,从而提高市场份额。
行业发展和未来机遇:
2021 年 1 月,Hologic Inc. 通过推出新型 SuperSonic MACH 20 超声系统。 Hologic Inc. 提供三个超声技术层,确保更多设施能够获得定制超声解决方案,以满足其独特的成像需求。该系统旨在提高效率和诊断准确性,具有高质量图像和创新成像模式,并提供直观的用户体验。2020 年 7 月,FUJIFILM Sonosite, Inc. 推出了新型 Sonosite PX 超声系统。 Sonosite PX 是 Sonosite POCUS 的下一代产品,具有 Sonosite 系统中最先进的图像清晰度、一套工作流程效率功能和适应性强的外形尺寸。 2020 年 3 月,EchoNous Inc. 宣布 FDA 批准其 KOSMOS 平台,该平台由独特的 8 盎司组成。基于超声的工具与深度学习相结合,用于心脏、肺和腹部的临床评估。它是医学领域第一个应用机器学习的数学框架来模仿人类学习和决策过程的工具。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving and restraining factors for the Australia and New Zealand point-of-care diagnostic ultrasound market?

The increasing use of point-of-care diagnostic ultrasound in emergency care and the high adoption of handheld devices are driving the growth of the Australia and New Zealand point-of-care diagnostic ultrasound market. However, the shortage of skilled technicians hinders market growth.

Which is the largest country in the Australia and New Zealand point-of-care diagnostic ultrasound market?

Australia is estimated to hold the largest share of the market. The market growth in the country is attributed to the rising number of chronic diseases that necessitate quick and efficient diagnosis tools like POCUS for timely identification, evaluation, and management.

Who are the key players in the Australia and New Zealand point-of-care diagnostic ultrasound market?

Companies operating in the market are GE Healthcare; Butterfly Network, Inc.; Fujifilm; Esoate SpA; Hologic, Inc; Echonous Inc; Koninklijke Philips NV; Shenzhen Mindray Bio-medical Electronics Co Ltd; and Clarius Mobile Health Corp.

What is the Australia and New Zealand point-of-care diagnostic ultrasound market growth?

The Australia and New Zealand point-of-care diagnostic ultrasound market is expected to grow at a compound annual growth rate of 5.2% from 2022 to 2030 to reach US$ 83.53 million by 2030.

What is the segmentation for the Australia and New Zealand point-of-care diagnostic ultrasound market?

The Australia and New Zealand point-of-care diagnostic ultrasound market is segmented on the basis of technology, portability, application, and end user. Based on technology, the market is segmented into 2D, 3D/4D, and others. Based on portability, the market is bifurcated into trolley and compact/handheld. In terms of application, the Australia and New Zealand point-of-care diagnostic ultrasound market is categorized into general imaging, cardiology, surgery, and others. Based on end user, the market is segmented into emergency, intensive care/critical care, operating theater, IVF clinics, physiotherapy centers, sports medicine, general practitioners, respiratory centers, anesthesia, and general wards.

The List of Companies - Australia and New Zealand Point-of-Care Diagnostic Ultrasound Market

  1. Hologic Inc
  2. Fujifilm Sonosite Inc
  3. GE Healthcare Technologies Inc
  4. Esaote Spa
  5. Echonous Inc
  6. Koninklijke Philips NV
  7. Shenzhen Mindray Bio-medical Electronics Co Ltd
  8. Clarius Mobile Health Corp
  9. Butterfly Network Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports